Omzet 2024 * | 117 mln. 110 mln. | Omzet 2025 * | 130 mln. 122 mln. | Marktkapitalisatie | 84,19 mln. 78,95 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -11 mln. -10,31 mln. | Nettowinst (verlies) 2025 * | 1 mln. 938K | EV/omzet 2024 * | 0,72 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,65 x |
K/w-verhouding 2024 * |
-7,38
x | K/w-verhouding 2025 * |
177
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,37% |
Recentste transcriptie over Depomed Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 01-02-19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 01-07-19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 06-03-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 01-11-03 |
James Tyree
BRD | Director/Board Member | 71 | 01-10-16 |
William McKee
BRD | Director/Board Member | 62 | 01-03-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,00% | 704 mld. | |
+25,90% | 577 mld. | |
-7,75% | 348 mld. | |
+18,53% | 327 mld. | |
+4,95% | 288 mld. | |
+15,19% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-4,89% | 147 mld. |